2024-11-05 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis Report

This report provides a comprehensive analysis of Teladoc Health Inc. (TDOC), a leading provider of telehealth services.  

**1. Performance Analysis:**

* **Cumulative Return:** TDOC has delivered a cumulative return of 50.85% compared to the S&P 500 (VOO) which has yielded 129.8%. This indicates a significant underperformance relative to the market. 
* **Relative Divergence:** The current relative divergence is -78.95%, which signifies that TDOC is currently underperforming the S&P 500 by a considerable margin, falling within the bottom 10% of historical performance. 
* **Alpha and Beta Analysis:** The company has exhibited high beta (average of 1.7) indicating higher volatility compared to the market. Alpha has varied considerably over the years, suggesting inconsistent performance compared to the market. 

**2. Recent Price Movements:**

* **Closing Price:** TDOC closed at $8.87. 
* **Moving Averages:** The stock is currently trading below its 5-day ($8.97), 20-day ($9.12) and 60-day ($8.28) moving averages, indicating a potential downward trend.

**3. Technical Indicators:**

* **RSI:** The RSI stands at 41.49, suggesting a neutral to slightly oversold condition.
* **PPO:** The PPO is -0.65, indicating a potential bearish signal. 
* **Delta_Previous_Relative_Divergence:** The recent 20-day relative divergence change is +0.09, indicating a short-term bullish signal.
* **Expected Return:** The expected return is 0.0%. This suggests that long-term investment in TDOC may not yield significant outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

* **Earnings:** Teladoc has experienced declining EPS and revenue over the past quarters, indicating a trend of decreasing profitability. The most recent earnings report for Q3 2024 revealed EPS of -$0.19, below analyst estimates. 
* **Financial Health:** The company has been experiencing a decline in revenue and profitability. The profit margin has been hovering around 70% for the past few quarters, but equity and ROE have fluctuated significantly.

**5. News and Recent Developments:**

* **Earnings News:** Teladoc's recent earnings report, released on [date], was met with mixed reactions. Some analysts expressed concerns about the declining profitability and sluggish growth. [Refer to specific news articles from Shacknews or other reputable sources].
* **Market Outlook:**  The market sentiment regarding Teladoc remains uncertain. [Refer to recent analyst reports from FINBOLD or other sources for a detailed market outlook and performance highlights].

**6. Comprehensive Analysis:**

* Teladoc has struggled to maintain its performance against the broader market, exhibiting significant underperformance and high volatility.
* The recent price movements suggest a potential downward trend, further supported by technical indicators like the PPO. 
* While the recent relative divergence change is positive, the overall market sentiment remains cautious due to the declining earnings and profitability. 
* The long-term outlook for TDOC is uncertain, with limited expected outperformance compared to the S&P 500.

**7. Recommendations:**

* **Short-Term:** Given the recent price trends and technical indicators, a cautious approach is recommended. 
* **Long-Term:**  Investors seeking long-term growth should carefully consider the uncertain outlook and declining profitability.
* **Diversification:** Diversifying investments across various sectors and asset classes can mitigate risk. 

This analysis should serve as a starting point for further research and due diligence. Investors should consult with a qualified financial advisor before making any investment decisions. 
